# A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

> clinical trial · VERIFIED · 2026-07-06

Status: RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Early Alzheimer's Disease

- Company: Merck Sharp & Dohme LLC
- Sector: Early Alzheimer's Disease
- Primary source: https://clinicaltrials.gov/study/NCT07033494

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.